Warby Parker Inc (WRBY)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE
Market Cap: $3.41B
Last updated: Nov 17, 2026 at 11:06 AM ET
Warby Parker Inc (WRBY) Earnings: Report Dates and Results
Warby Parker (WRBY) is expected to report earnings on Feb 24, 2027. In the quarter ended Sep 30, 2026, Warby Parker reported EPS of $0.05, above the $0.03 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
WRBY has an expected report date of Feb 24, 2027.
WRBY Earnings Call
The latest WRBY earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 21 quarters below that had an estimate, WRBY beat 11, missed 4 and matched 6. Revenue for the quarter ended Sep 30, 2026 was $244.74M, up 10.4% from $221.68M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.05 | $0.03 | N/A | +66.67% | Beat | -58.3% | 9 | 0 up, 0 down | Nov 5, 2026 | $244.74M |
| Jun 30, 2026 | $0.05 | $0.05 | N/A | 0.00% | In line | +150.0% | 10 | 2 up, 8 down | Aug 6, 2026 | $235.51M |
| Mar 31, 2026 | $0.11 | $0.11 | $0.09 - $0.13 | 0.00% | In line | -21.4% | 10 | 1 up, 0 down | May 7, 2026 | $242.45M |
| Dec 31, 2025 | -$0.04 | $0.01 | N/A | -500.00% | Miss | N/A | 9 | 1 up, 0 down | Feb 26, 2026 | $211.97M |
| Sep 30, 2025 | $0.12 | $0.09 | $0.07 - $0.12 | +33.33% | Beat | +100.0% | 10 | 9 up, 1 down | Nov 6, 2025 | $221.68M |
| Jun 30, 2025 | $0.02 | $0.02 | N/A | 0.00% | In line | -75.0% | 10 | 1 up, 0 down | Aug 7, 2025 | $214.47M |
| Mar 31, 2025 | $0.14 | $0.11 | $0.10 - $0.14 | +27.27% | Beat | +27.3% | 8 | 2 up, 3 down | May 8, 2025 | $223.78M |
| Dec 31, 2024 | -$0.06 | $0.03 | $0.01 - $0.06 | -300.00% | Miss | N/A | 9 | 4 up, 2 down | Feb 27, 2025 | $190.64M |
| Sep 30, 2024 | $0.06 | $0.05 | $0.03 - $0.07 | +20.00% | Beat | +500.0% | 7 | 1 up, 0 down | Nov 7, 2024 | $192.45M |
| Jun 30, 2024 | $0.08 | $0.05 | $0.04 - $0.06 | +60.00% | Beat | +100.0% | 7 | 0 up, 0 down | Aug 8, 2024 | $188.22M |
| Mar 31, 2024 | $0.11 | $0.07 | $0.06 - $0.08 | +57.14% | Beat | +83.3% | 7 | 0 up, 1 down | May 9, 2024 | $200.00M |
| Dec 31, 2023 | -$0.01 | $0.01 | $0.00 - $0.02 | -200.00% | Miss | N/A | 7 | 0 up, 0 down | Feb 28, 2024 | $161.85M |
| Sep 30, 2023 | $0.01 | $0.01 | $0.00 - $0.02 | 0.00% | In line | 0.0% | 9 | 0 up, 0 down | Nov 8, 2023 | $169.85M |
| Jun 30, 2023 | $0.04 | $0.02 | $0.02 - $0.03 | +100.00% | Beat | N/A | 7 | 0 up, 0 down | Aug 9, 2023 | $166.09M |
| Mar 31, 2023 | $0.06 | $0.04 | $0.03 - $0.06 | +50.00% | Beat | N/A | 7 | 2 up, 0 down | May 9, 2023 | $171.97M |
| Dec 31, 2022 | -$0.18 | $0.00 | -$0.01 - $0.01 | N/A | N/A | N/A | 7 | 1 up, 0 down | Feb 28, 2023 | $146.49M |
| Sep 30, 2022 | $0.01 | $0.01 | $0.00 - $0.02 | 0.00% | In line | -50.0% | 6 | 0 up, 1 down | Nov 10, 2022 | $148.78M |
| Jun 30, 2022 | -$0.01 | -$0.02 | N/A | +50.00% | Beat | N/A | N/A | 0 up, 1 down | Aug 11, 2022 | $149.62M |
| Mar 31, 2022 | -$0.04 | -$0.04 | -$0.04 - $0.05 | 0.00% | In line | N/A | 7 | 0 up, 0 down | May 16, 2022 | $153.22M |
| Dec 31, 2021 | -$0.08 | -$0.09 | -$0.12 - -$0.02 | +11.11% | Beat | N/A | 6 | N/A | Mar 17, 2022 | $132.89M |
| Sep 30, 2021 | $0.02 | -$0.22 | -$0.71 - $0.44 | +109.09% | Beat | N/A | 6 | N/A | Nov 12, 2021 | $137.37M |
| Jun 30, 2021 | -$0.11 | -$0.05 | N/A | -120.00% | Miss | N/A | N/A | N/A | Sep 29, 2021 | $131.56M |
| Mar 31, 2021 | -$0.19 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 30, 2021 | $138.97M |
| Dec 31, 2020 | -$0.19 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2021 | $112.84M |
| Mar 31, 2020 | -$0.10 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 29, 2020 | $88.39M |
| Dec 31, 2019 | -$0.10 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2020 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $0.24, up 26.3% from the year before. It was -$0.10 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $0.24 | +26.3% |
| Dec 31, 2024 | $0.19 | +90.0% |
| Dec 31, 2023 | $0.10 | N/A |
| Dec 31, 2022 | -$0.22 | N/A |
| Dec 31, 2021 | -$0.36 | N/A |
| Dec 31, 2020 | -$0.28 | N/A |
| Dec 31, 2019 | -$0.10 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 7,900 words across 13 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 7,925 | 13 | |
| 2026Q2 | Jun 30, 2026 | 8,214 | 11 | |
| 2026Q1 | Mar 31, 2026 | 8,146 | 12 | |
| 2025Q4 | Dec 31, 2025 | 8,671 | 12 | |
| 2025Q3 | Sep 30, 2025 | 7,383 | 12 | |
| 2025Q2 | Jun 30, 2025 | 7,168 | 10 | |
| 2025Q1 | Mar 31, 2025 | 7,081 | 12 | |
| 2024Q4 | Dec 31, 2024 | 8,432 | 11 |
2026Q3 Earnings Call
Opening remarks
Jaclyn Berkley Head of Investor Relations Thank you, and good morning, everyone. With me today are Neil Harris Blumenthal and David Abraham Gilboa, our cofounders and co-CEOs, alongside Adrian Mitchell, our Chief Financial Officer. Before we begin, we have a couple of reminders. Our earnings release and slide presentation are available on our website at investors.warbyparker.com. During this call and in our presentation, we will be making comments of a forward-looking nature. Actual results may differ materially from those expressed or implied as a result of various risks and uncertainties. For more information about some of these risks, please review the company's SEC filings, including the section titled Risk Factors in the company's latest annual report on Form 10-K. These forward-looking statements are based on information as of November 5, 2026. Except as required by law, we assume no obligation to publicly update or revise our forward-looking statements. Additionally, we will be discussing certain non-GAAP financial measures. These non-GAAP financial measures are in addition to, and not a substitute for, measures of financial performance prepared in accordance with U.S. GAAP. A reconciliation of our non-GAAP measures to the most directly comparable U.S. GAAP measures can be found in this morning's press release and our slide deck available on our IR website. With that, I will pass it over to David to kick us off.
David Abraham Gilboa Co-CEO Thank you, Jaclyn, and good morning. Throughout 2026, we have made significant investments in our most important long-term growth initiatives while continuing to execute against the core business. In the third quarter, we delivered revenue growth of 10.4% and adjusted EBITDA above our guidance, even as we lapped our strongest revenue growth and highest margin expansion of last year. We delivered this level of profitability while balancing a number of investments and initiatives across the business. We are continuing to focus on opportunities that we believe can drive stronger top-line growth in the years ahead. We are already seeing progress across several of these areas. We have opened 41 net new stores year to date, ahead of last year's pace, further expanding the reach of our brand and holistic eye care offering. E-commerce growth accelerated to 5%, its strongest quarterly growth since we sunset Home Try-On, while eye exams and insurance grew 30% and 22% year over year, respectively. These are areas we have been investing in for years, and we are encouraged by the momentum we are seeing as they become increasingly meaningful contributors to our growth. We are also introducing newness to our assortment, including today's launch of our collaboration with Rare Beauty by Selena Gomez, which enables us to reach new audiences.
Frequently Asked Questions About WRBY
When is Warby Parker's next earnings date?
Warby Parker's next earnings report is expected for Feb 24, 2027.
Did WRBY beat earnings estimates last quarter?
Yes. Warby Parker reported EPS of $0.05 for the quarter ended Sep 30, 2026, above the $0.03 estimate, a 66.67% surprise.
What EPS do analysts expect from WRBY next quarter?
The consensus EPS estimate for Warby Parker for the quarter ending Dec 31, 2026 is $0.10 from 15 analysts, with estimates from $0.08 to $0.14.
How often does WRBY beat earnings estimates?
Warby Parker beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -84.09%.
WRBY pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors